Beneficial ownership — 13D / 13G
85,706 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | PETS Petmed Express Inc | 13G | 6.36% | Aug 23, 2023 | 2y |
| RENAISSANCE TECHNOLOGIES LLC | SLCA U.S. SILICA HOLDINGS, INC. | 13G | 5.14% | May 10, 2023 | 2y |
| Trailblazer Sponsor Group, LLC | TBMC Trailblazer Merger Corp I | 13G | 23.5% | Mar 31, 2023 | 2y |
| Phoenix Financial Ltd. | GILT Gilat Satellite Networks Ltd | 13D | 21.19% | Mar 17, 2023 | 2y |
| RENAISSANCE TECHNOLOGIES LLC | GASS StealthGas Inc. | 13G | 6.01% | Mar 1, 2023 | 2y |
| RENAISSANCE TECHNOLOGIES LLC | APT Alpha Pro Tech Ltd | 13G | 5.05% | Jan 27, 2023 | 2y |
| William Guest Bollinger | NGD New Gold Inc. | 13G/A | 7.7% | Dec 31, 2022 | 2y |
| Eric Easom | ANTX AN2 Therapeutics, Inc. | 13G | 5.2% | Dec 31, 2022 | 2y |
| Dr. Stephen Mulholland | INMD InMode Ltd. | 13G/A | 5.84% | Dec 31, 2022 | 2y |
| Serguei Melnik | NTRB NutriBand Inc. | 13G | 9.26% | Feb 15, 2022 | 2y |
| PLATINUM EQUITY, LLC | UWMC UWM Holdings Corp | 13G | 7.2% | Dec 31, 2021 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | MLYS Mineralys Therapeutics, Inc. | 13D/A | 9.99% | Feb 12, 2024 | 2y |
| Nan Fung Group Holdings Limited | RLYB Rallybio Corp | 13D/A | 6.4% | Feb 12, 2024 | 2y |
| Samsara BioCapital, L.P. | MLYS Mineralys Therapeutics, Inc. | 13D/A | 10.3% | Feb 12, 2024 | 2y |
| Nan Fung Group Holdings Limited | INZY Inozyme Pharma, Inc. Common Stock | 13D/A | 7.2% | Feb 12, 2024 | 2y |
| Liberty TripAdvisor Holdings, Inc. | TRIP TripAdvisor, Inc. | 13D/A | 21.1% | Feb 9, 2024 | 2y |
| CIIG Management III LLC | CPTKW Crown PropTech Acquisitions | 13D/A | 63.6% | Feb 9, 2024 | 2y |
| URANIUM ENERGY CORP | UROY Uranium Royalty Corp. | 13D/A | 14.96% | Feb 9, 2024 | 2y |
| MFN Partners, LP | RXO RXO, Inc. | 13G/A | 13.3% | Feb 9, 2024 | 2y |
| Great Elm Group, Inc. | GECC Great Elm Capital Corp. | 13D/A | 16.1% | Feb 8, 2024 | 2y |
| TPG GP A, LLC | HOUS Anywhere Real Estate Inc. | 13D/A | 8.8% | Feb 8, 2024 | 2y |
| Bertelsmann SE & Co. KGaA | AFYA Afya Ltd | 13D/A | 61.86% | Feb 8, 2024 | 2y |
| Cano Health, Inc. | MSPR MSP Recovery, Inc. | 13D/A | 35.6% | Feb 8, 2024 | 2y |
| REH Company | DINO HF Sinclair Corp | 13D/A | 13.3% | Feb 8, 2024 | 2y |
| OCO Capital GP LLC | GEME Pacific North of South EM Equity Active ETF | 13G/A | 4.94% | Feb 8, 2024 | 2y |
| WHITMORE BRADFORD T | SLSN Solesence, Inc. | 13D/A | 63.7% | Feb 8, 2024 | 2y |
| Michael Jonas | ZDGE Zedge, Inc. | 13D/A | 14.2% | Feb 8, 2024 | 2y |
| Coliseum Capital Management, LLC | GMS GMS Inc. | 13D/A | 6.6% | Feb 8, 2024 | 2y |
| Jacobsen Per A. | BLIN Bridgeline Digital, Inc. | 13G/A | 7.1% | Feb 8, 2024 | 2y |
| Carlyle Group Inc. | JSPR Jasper Therapeutics, Inc. | 13D/A | 7.1% | Feb 8, 2024 | 2y |
| Strategic Value Investors LP | BFIN BankFinancial Corporation | 13D | 5.2% | Feb 7, 2024 | 2y |
| Ionic Ventures, LLC | PRSO Peraso Inc. | 13G | 9.9% | Feb 6, 2024 | 2y |
| I.B.F Management Ltd. | ADXS Advaxis, Inc. | 13D/A | 71.63% | Feb 5, 2024 | 2y |
| Paul Saunders, Jr. | APT Alpha Pro Tech Ltd | 13G/A | 0.4% | Feb 5, 2024 | 2y |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | CRBP Corbus Pharmaceuticals Holdings, Inc. | 13G | 7.7% | Feb 2, 2024 | 2y |
| Deep Track Capital, LP | IVVD Invivyd, Inc. | 13G | 7.56% | Feb 2, 2024 | 2y |
| Mitchell P. Kopin | NVVE Nuvve Holding Corp. | 13G | 8.9% | Feb 2, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | CRBP Corbus Pharmaceuticals Holdings, Inc. | 13G | 4.1% | Feb 2, 2024 | 2y |
| Point72 Asset Management, L.P. | ANNX Annexon, Inc. | 13G | 6.2% | Feb 2, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | RYTM Rhythm Pharmaceuticals, Inc. | 13G | 5.5% | Feb 1, 2024 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | ATXS Astria Therapeutics, Inc. Common Stock | 13G | 8.1% | Feb 1, 2024 | 2y |
| ICAHN CARL C | JBLU Jetblue Airways Corp | 13D | 9.91% | Feb 1, 2024 | 2y |
| Polus Capital Management Ltd | SDRL SEADRILL Ltd | 13G/A | 0.3% | Jan 31, 2024 | 2y |
| VANGUARD GROUP INC | SMAR Smartsheet Inc. | 13G/A | 10.01% | Jan 31, 2024 | 2y |
| VANGUARD GROUP INC | OPI Office Properties Income Trust | 13G/A | 10.04% | Jan 31, 2024 | 2y |
| VANGUARD GROUP INC | OMF OneMain Holdings, Inc. | 13G/A | 10.17% | Jan 31, 2024 | 2y |
| T. Rowe Price Investment Management, Inc. | CPK Chesapeake Utilities Corp | 13G/A | 10.1% | Jan 31, 2024 | 2y |
| VANGUARD GROUP INC | BIIB Biogen Inc. | 13G/A | 10.02% | Jan 31, 2024 | 2y |
| VANGUARD GROUP INC | KBH Kb Home | 13G/A | 10.26% | Jan 31, 2024 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | KYMR Kymera Therapeutics, Inc. | 13G/A | 10.1% | Jan 31, 2024 | 2y |